CT
LABU icon

CMT Trading’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

CMT Trading’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-145
Closed -$270K – 19
2018
Q3 		$270K Buy
+145
New +$285K 0.68% 14
2017
Q4 		– Sell
-287
Closed -$491K – 25
2017
Q3 		$491K Buy
+287
New +$398K 0.81% 13
2017
Q2 		– Sell
-367
Closed -$350K – 31
2017
Q1 		$350K Buy
+367
New +$327K 0.48% 25
2016
Q4 		– Sell
-238
Closed -$232K – 40
2016
Q3 		$232K Sell
238
-985
-81% -$813K 0.17% 33
2016
Q2 		$690K Buy
1,223
+459
+60% +$288K 1.17% 18
2016
Q1 		$419K Buy
+764
New +$483K 1.32% 20

Other funds holding LABU

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CMT Trading's LABU Position: Q4 2018 in Review

CMT Trading sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2018, closing a stake of 145 shares — an estimated $270K sold.

CMT Trading first reported a position in LABU in Q1 2016 and held it in 6 quarters. The position peaked at $690K in Q2 2016. 30 funds tracked by Wall St. Rank hold LABU as of Q4 2018.

  • CMT Trading reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2018 after selling out during the quarter.
  • CMT Trading sold 145 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2018, an estimated $270K.
  • CMT Trading first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2016 and held it in 6 quarters.
  • CMT Trading's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $690K in Q2 2016.
  • 30 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2018.

Based on CMT Trading's 13F filing for Q4 2018, filed 14 Feb 2019.